Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla-C Dubinsky

Showing results (131-140 of 247) with videos related to

Pageof 25
Sort By:
Digestive Diseases and Sciences|March 17, 2024
Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel DiseaseChelsea A DeBolt, Zoë S Gottlieb, Manasa G Rao, et al.
Pharmaceutics|February 26, 2025
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel DiseaseAndres J Yarur, Thierry Dervieux, Ryan Ungaro, et al.
Journal of Crohn'S & Colitis|December 9, 2023
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 StudiesJean-Frederic Colombel, Stefan Schreiber, Geert D'Haens, et al.
The American Journal of Surgical Pathology|August 19, 2004
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel diseaseStephen A Geller, Marla C Dubinsky, F Fred Poordad, et al.
Journal of Crohn'S & Colitis|June 26, 2018
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2Frank M Ruemmele, Joel Rosh, William A Faubion, et al.
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
BMJ Open Gastroenterology|March 31, 2023
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitisMarla C Dubinsky, Vipul Jairath, Brian G Feagan, et al.
Inflammatory Bowel Diseases|March 8, 2016
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's DiseaseMarla C Dubinsky, Joel Rosh, William A Faubion, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Pageof 25

Showing results (131-140 of 247) with videos related to

Sort By:
Pageof 25
Digestive Diseases and Sciences|March 17, 2024
Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel DiseaseChelsea A DeBolt, Zoë S Gottlieb, Manasa G Rao, et al.
Pharmaceutics|February 26, 2025
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel DiseaseAndres J Yarur, Thierry Dervieux, Ryan Ungaro, et al.
Journal of Crohn'S & Colitis|December 9, 2023
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 StudiesJean-Frederic Colombel, Stefan Schreiber, Geert D'Haens, et al.
The American Journal of Surgical Pathology|August 19, 2004
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel diseaseStephen A Geller, Marla C Dubinsky, F Fred Poordad, et al.
Journal of Crohn'S & Colitis|June 26, 2018
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2Frank M Ruemmele, Joel Rosh, William A Faubion, et al.
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
BMJ Open Gastroenterology|March 31, 2023
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitisMarla C Dubinsky, Vipul Jairath, Brian G Feagan, et al.
Inflammatory Bowel Diseases|March 8, 2016
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's DiseaseMarla C Dubinsky, Joel Rosh, William A Faubion, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Pageof 25